Literature DB >> 31273787

Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes.

Norimitsu Morioka1, Kazuki Miyauchi1, Keita Miyashita1, Takahiro Kochi1, Fang Fang Zhang1,2, Yoki Nakamura1,3, Keyue Liu4, Hidenori Wake4, Kazue Hisaoka-Nakashima1, Masahiro Nishibori4, Yoshihiro Nakata1.   

Abstract

Intrathecal treatment with recombinant high-mobility group box-1 (rHMGB1) in naïve mice leads to a persistent and significantly decreased hind paw withdrawal threshold to mechanical stimuli, suggesting that spinal HMGB1 evokes abnormal pain processing. By contrast, repeated intrathecal treatment with anti-HMGB1 antibody significantly reverses hind paw mechano-hypersensitivity in mice with a partial sciatic nerve ligation (PSNL). By contrast, the cellular mechanism by which spinal HMGB1 induces neuropathic pain has yet to be fully elaborated. The current study tested the hypothesis that spinal HMGB1 could induce mechanical hypersensitivity through the activation of specific receptor in glial cells. Intrathecal pretreatment with toll-like receptor (TLR) 4 inhibitors, but not TLR5, receptor for advanced glycation end-products and C-X-C chemokine receptor type 4 inhibitors, prevented rHMGB1-evoked mechanical hypersensitivity. Activation of spinal astrocytes appears to be crucial for the mechanism of action of rHMGB1 in naïve mice, as intrathecal pretreatment with astrocytic inhibitors prevented the rHMGB1-induced mechanical hypersensitivity. Interleukin-1β (IL-1β) was up-regulated within activated astrocytes and block of TLR4 prevented the upregulation of IL-1β. Interleukin-1β appears to be secreted by activated astrocytes, as IL-1β neutralizing antibody prevented rHMGB1-induced mechanical hypersensitivity. Furthermore, intrathecal pretreatment with either MK801 or gabapentin prevented the rHMGB1-induced mechanical hypersensitivity, suggesting roles for spinal glutamate and the N-methyl-d-aspartate receptor in the mediation of rHMGB1-induced mechanical hypersensitivity. Thus, the current findings suggest that spinal HMGB1 upregulates IL-1β in spinal astrocytes through a TLR4-dependent pathway and increases glutamatergic nociceptive transduction. These spinal mechanisms could be key steps that maintain neuropathic pain.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  HMGB1; TLR4; allodynia; glutamate; interleukin-1β; neuropathic pain

Mesh:

Substances:

Year:  2019        PMID: 31273787     DOI: 10.1111/jnc.14812

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Oleanolic acid administration alleviates neuropathic pain after a peripheral nerve injury by regulating microglia polarization-mediated neuroinflammation.

Authors:  Xuyang Li; Guangzhi Wu; Miyang Li; Zhan Zhang
Journal:  RSC Adv       Date:  2020-04-01       Impact factor: 4.036

2.  Anti-HMGB1 auto-Abs influence fatigue in patients with Crohn's disease.

Authors:  Ingeborg Kvivik; Tore Grimstad; Grete Jonsson; Jan T Kvaløy; Roald Omdal
Journal:  Innate Immun       Date:  2021-05-03       Impact factor: 2.680

Review 3.  Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Fumiko Sekiguchi; Atsufumi Kawabata
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

4.  GSK2593074A blocks progression of existing abdominal aortic dilation.

Authors:  Mitri K Khoury; Ting Zhou; Huan Yang; Samantha R Prince; Kartik Gupta; Amelia R Stranz; Qiwei Wang; Bo Liu
Journal:  JVS Vasc Sci       Date:  2020-07-28

Review 5.  Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.

Authors:  Peng Zhang; Meirong Yang; Chunhua Chen; Liu Liu; Xinchuan Wei; Si Zeng
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.